论文部分内容阅读
海正辉瑞制药有限公司简介海正辉瑞制药有限公司(以下简称海正辉瑞),成立于2012年9月13日,由海正药业与辉瑞制药共同出资建立。历时三年筹备,强强联手,以前瞻视角成就战略合作。是一家独立运营从事成品制剂研发、生产、营销的中外合资有限公司。作为全球500强企业与中国本土制药企业间规模最大的中外合资制药项目,海正辉瑞总投资2.95亿美元,注册资本2.5亿美元。生产基地位于浙江省富阳市,拥有国际最先进的生产设备,耗资15亿建设包括
About Haizheng Pfizer Pharmaceutical Co., Ltd. Haizheng Pfizer Pharmaceutical Co., Ltd. (hereinafter referred to as Haizheng Pfizer) was established on September 13, 2012 and is jointly funded by Hisun Pharmaceutical and Pfizer. It lasted for three years to prepare and make joint efforts to achieve strategic cooperation with a forward-looking perspective. Is an independent operation in finished product research and development, production and marketing of Sino-foreign joint ventures Limited. As the largest Sino-foreign joint venture between top 500 global pharmaceutical companies and Chinese local pharmaceutical companies, Hisun Pfizer has a total investment of 295 million U.S. dollars and a registered capital of 250 million U.S. dollars. Production base is located in Fuyang City, Zhejiang Province, with the most advanced production equipment, cost 1.5 billion construction including